These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28823891)

  • 21. From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies.
    Mignani S; Majoral JP; Desaphy JF; Lentini G
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32707914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice.
    Del Signore SJ; Amante DJ; Kim J; Stack EC; Goodrich S; Cormier K; Smith K; Cudkowicz ME; Ferrante RJ
    Amyotroph Lateral Scler; 2009 Apr; 10(2):85-94. PubMed ID: 18618304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Spatiotemporal Pattern of Degeneration in the Cerebellum of the Wobbler Mouse.
    Saberi D; Ott B; Dahlke C; Matschke V; Schmitt-John T; Theiss C
    J Neuropathol Exp Neurol; 2016 Apr; 75(4):347-57. PubMed ID: 26945034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
    Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Zis V; Sfagos C; Vassilopoulos D
    Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis.
    Vercruysse P; Sinniger J; El Oussini H; Scekic-Zahirovic J; Dieterlé S; Dengler R; Meyer T; Zierz S; Kassubek J; Fischer W; Dreyhaupt J; Grehl T; Hermann A; Grosskreutz J; Witting A; Van Den Bosch L; Spreux-Varoquaux O; ; Ludolph AC; Dupuis L
    Brain; 2016 Apr; 139(Pt 4):1106-22. PubMed ID: 26984187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease.
    Ishiyama T; Okada R; Nishibe H; Mitsumoto H; Nakayama C
    Brain Res; 2004 Sep; 1019(1-2):226-36. PubMed ID: 15306257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model.
    Waibel S; Reuter A; Malessa S; Blaugrund E; Ludolph AC
    J Neurol; 2004 Sep; 251(9):1080-4. PubMed ID: 15372249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Riluzole--what is its impact in our treatment and understanding of amyotrophic lateral sclerosis?
    Mitsumoto H
    Ann Pharmacother; 1997 Jun; 31(6):779-81. PubMed ID: 9184724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Edaravone, a Free Radical Scavenger, Delayed Symptomatic and Pathological Progression of Motor Neuron Disease in the Wobbler Mouse.
    Ikeda K; Iwasaki Y
    PLoS One; 2015; 10(10):e0140316. PubMed ID: 26469273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis.
    Dyer AM; Smith A
    Drug Des Devel Ther; 2017; 11():59-64. PubMed ID: 28053507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demonstrated hormetic mechanisms putatively subserve riluzole-induced effects in neuroprotection against amyotrophic lateral sclerosis (ALS): Implications for research and clinical practice.
    Calabrese EJ; Calabrese V; Giordano J
    Ageing Res Rev; 2021 May; 67():101273. PubMed ID: 33571705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of riluzole (Rilutek) treatment on plasma amino acid percentages in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
    Neurol Sci; 2003 Nov; 24(4):290-2. PubMed ID: 14658053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood pressure elevations in riluzole-treated patients with amyotrophic lateral sclerosis.
    Scelsa SN; Khan I
    Eur Neurol; 2000; 43(4):224-7. PubMed ID: 10828653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic inhibitory effect of riluzole on trophic factor production.
    Dennys CN; Armstrong J; Levy M; Byun YJ; Ramdial KR; Bott M; Rossi FH; Fernández-Valle C; Franco MC; Estevez AG
    Exp Neurol; 2015 Sep; 271():301-7. PubMed ID: 26071088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysfunctional mitochondrial respiration in the wobbler mouse brain.
    Xu GP; Dave KR; Moraes CT; Busto R; Sick TJ; Bradley WG; Pérez-Pinzón MA
    Neurosci Lett; 2001 Mar; 300(3):141-4. PubMed ID: 11226631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice.
    Meyer M; Gonzalez Deniselle MC; Hunt H; de Kloet ER; De Nicola AF
    J Steroid Biochem Mol Biol; 2014 Sep; 143():40-8. PubMed ID: 24565565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent blockade of free radical and microsomal prostaglandin E synthase-1-mediated PGE2 production improves safety and efficacy in a mouse model of amyotrophic lateral sclerosis.
    Shin JH; Lee YA; Lee JK; Lee YB; Cho W; Im DS; Lee JH; Yun BS; Springer JE; Gwag BJ
    J Neurochem; 2012 Sep; 122(5):952-61. PubMed ID: 22537108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An association study of riluzole serum concentration and survival and disease progression in patients with ALS.
    Groeneveld GJ; van Kan HJ; Lie-A-Huen L; Guchelaar HJ; van den Berg LH
    Clin Pharmacol Ther; 2008 May; 83(5):718-22. PubMed ID: 17898704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anti-ALS drug riluzole attenuates pericyte loss in the diabetic retinopathy of streptozotocin-treated mice.
    Choi JA; Chung YR; Byun HR; Park H; Koh JY; Yoon YH
    Toxicol Appl Pharmacol; 2017 Jan; 315():80-89. PubMed ID: 27939241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.